Valuation: Stryker Corporation

Market Cap 130B 112B 105B 96.36B 181B 12,376B 184B 1,232B 484B 6,203B 488B 478B 20,508B P/E 2026 *
26.3x
P/E 2027 * 22.9x
Enterprise Value 139B 120B 112B 103B 194B 13,245B 197B 1,319B 518B 6,639B 523B 511B 21,947B EV / Sales 2026 *
5.1x
EV / Sales 2027 * 4.58x
Free-Float
94.9%
Yield 2026 *
1.06%
Yield 2027 * 1.13%
1 week+3.79%
Current month+3.79%
1 month+3.01%
1 week 13.3
Extreme 13.3
13.9
1 month 12.6
Extreme 12.6
14.4
Current year 12
Extreme 12
14.4
1 year 12
Extreme 12
14.4
3 years 12
Extreme 12
14.4
5 years 12
Extreme 12
14.4
10 years 12
Extreme 12
14.4
Manager TitleAgeSince
Chief Executive Officer 60 2012-09-30
Director of Finance/CFO 50 2025-03-31
President 49 2025-12-31
Director TitleAgeSince
Director/Board Member 82 1973-12-31
Director/Board Member 71 1983-12-31
Chairman 60 2014-07-21
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+3.79% - - 129B
+0.47%+4.09%-9.92%+18.43% 129B
+1.37%-3.93%-17.22%-0.67% 12.43B
+5.28%+7.98%+104.57%+139.45% 10.08B
+2.59%-3.43%-43.52%-67.91% 4.58B
+2.93%+3.12%-22.39%+42.74% 2.62B
+2.16%+19.82%-21.92%-77.34% 1.7B
+2.82%+0.80%-14.07%-12.55% 1.64B
+2.16%-0.93%-31.19%-27.86% 1.63B
Average +2.20%+3.40%-6.96%+1.79% 20.51B
Weighted average by Cap. +0.55%+3.63%-4.95%+20.63%

Financials

2026 *2027 *
Net sales 27.29B 23.61B 22.05B 20.22B 38.04B 2,597B 38.64B 259B 102B 1,302B 102B 100B 4,304B 29.68B 25.67B 23.98B 21.99B 41.37B 2,825B 42.03B 281B 110B 1,416B 111B 109B 4,681B
Net income 4.94B 4.27B 3.99B 3.66B 6.89B 470B 7B 46.83B 18.38B 236B 18.56B 18.15B 779B 5.75B 4.97B 4.64B 4.26B 8.01B 547B 8.14B 54.46B 21.37B 274B 21.58B 21.11B 906B
Net Debt 9.13B 7.89B 7.37B 6.76B 12.72B 868B 12.92B 86.48B 33.94B 435B 34.27B 33.52B 1,439B 5.89B 5.09B 4.76B 4.36B 8.21B 560B 8.34B 55.8B 21.9B 281B 22.11B 21.63B 929B
Logo Stryker Corporation
Stryker Corporation is one of the world's leaders in designing, manufacturing and marketing medical equipment and devices in the fields of medical surgery, neurotechnology and orthopaedics. Net sales break down by family of products as follows: - surgical equipment and neurotechnology products (62.3%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipment, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (37.7%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2025, the group had 55 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (75.7%), Europe/Middle East/Africa (12.7%), Asia/Pacific (8.6%) and other (3%).
Employees
56,000
Date Price Change
26-08-07 €13.70 0.00%
26-08-06 €13.70 0.00%
26-08-05 €13.70 -1.44%
26-08-04 €13.90 +4.51%
26-08-03 €13.30 +0.76%
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
339.03USD
Average target price
382.04USD
Spread / Average Target
+12.69%

Quarterly revenue - Rate of surprise